NASDAQ: TRVI
Trevi Therapeutics Inc Stock Ownership - Who owns Trevi Therapeutics?

Insider buying vs selling

Have Trevi Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher GallettaController and Principal Accounting Officer2025-12-024,225$0.51
$2.16kBuy

1 of 1

TRVI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRVI insiders and whales buy or sell their stock.

TRVI Shareholders

What type of owners hold Trevi Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Forest Baskett15.98%22,694,708$418.26MInsider
Peter W. Sonsini12.19%17,308,374$318.99MInsider
Mohamad Makhzoumi9.98%14,171,176$261.17MInsider
Carmen Chang9.98%14,171,176$261.17MInsider
Scott D. Sandell9.98%14,171,176$261.17MInsider
Paul Edward Walker9.98%14,171,176$261.17MInsider
Anthony A. Florence Jr.9.98%14,171,176$261.17MInsider
Ali Behbahani9.98%14,171,176$261.17MInsider
Nea Management Company LLC9.31%13,222,228$243.69MInstitution
New Enterprise Associates 16 LP8.64%12,273,280$226.20MInsider

1 of 3

TRVI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRVI43.91%56.09%Net Buying
IMNM96.16%3.84%Net SellingNet Selling
ATAI27.07%32.68%Net BuyingNet Buying
RARE84.29%15.71%Net SellingNet Selling
TARS73.41%26.59%Net SellingNet Selling

Trevi Therapeutics Stock Ownership FAQ

Who owns Trevi Therapeutics?

Trevi Therapeutics (NASDAQ: TRVI) is owned by 95.04% institutional shareholders, 121.40% Trevi Therapeutics insiders, and 0.00% retail investors. Forest Baskett is the largest individual Trevi Therapeutics shareholder, owning 22.69M shares representing 15.98% of the company. Forest Baskett's Trevi Therapeutics shares are currently valued at $418.26M.

If you're new to stock investing, here's how to buy Trevi Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.